# Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers

> **NCT03151499** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 409306
- **DRUG:** Rifampicin

## Key facts

- **NCT ID:** NCT03151499
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-30
- **Primary completion:** 2017-07-11
- **Final completion:** 2017-07-11
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03151499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03151499, "Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03151499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*